background
previous
report
experiment
infect
young
adult
histori
episod
exclus
viral
wheez
evw
use
human
coronaviru
evw
atop
healthi
control
seven
atop
develop
symptomat
cold
evid
infect
evw
develop
lower
respiratori
tract
symptom
increas
airway
respons
object
aim
studi
compar
evw
control
group
studi
inflammatori
chang
occur
upper
lower
respiratori
tract
experiment
infect
particular
determin
whether
eosinophildriven
inflamm
associ
evw
method
nasal
lavag
induc
sputum
collect
prior
inocul
day
day
later
differenti
cell
count
perform
supernat
assay
ifng
eosinophil
cation
protein
ecp
result
differ
two
group
measur
baselin
group
cold
volum
nasal
secret
increas
leucocyt
count
upper
lower
respiratori
tract
modest
increas
nasal
neutrophil
count
seen
evw
control
group
symptomat
cold
day
median
quartil
differ
baselin
ml
secret
respect
chang
nasal
neutrophil
count
subject
correl
nasal
symptom
score
signific
rel
increas
sputum
differenti
neutrophil
count
seen
day
evw
group
cold
control
mean
differ
confid
interv
respect
howev
increas
correl
lower
respiratori
tract
symptom
score
increas
upper
lower
respiratori
tract
evw
control
subject
cold
largest
chang
seen
day
sputum
evw
mean
differ
baselin
confid
interv
ngml
modest
chang
seen
ifng
chang
seen
ecp
none
result
influenc
atop
statu
subject
either
group
conclus
evw
wheez
character
neutrophil
inflamm
upper
lower
respiratori
tract
without
eosinophilia
even
atop
subject
like
import
chemokin
process
symptom
airway
respons
correl
chang
neutrophil
exclus
viral
wheez
evw
asthma
phenotyp
occur
predominantli
young
children
common
upper
respiratori
tract
viral
infect
without
progress
chronic
airway
inflamm
persist
symptom
associ
atop
asthma
aftermath
evw
detect
adult
life
confirm
exist
experiment
young
adult
due
difficulti
perform
invas
measur
young
children
littl
inform
cellular
mechan
evw
age
group
opportunist
bronchoalveolar
lavag
bal
anaesthesia
shown
rel
absenc
inflammatori
cell
children
viral
wheez
episod
contrast
atop
asthma
publish
data
inflamm
respiratori
tract
episod
viral
wheez
although
evid
suggest
respiratori
tract
inflamm
like
involv
come
studi
inflamm
upper
respiratori
tract
urt
lower
respiratori
tract
lrt
healthi
asthmat
volunt
wildtyp
experiment
infect
usual
human
rhinoviru
hrv
urt
inflamm
cold
well
describ
predominantli
involv
neutrophil
influx
releas
cytokin
chemokin
attract
activ
inflammatori
cell
airway
mucosa
sampl
nasal
secret
solubl
mediat
includ
tnfa
ifng
groa
eosinophil
cation
protein
ecp
lrt
tract
also
known
becom
inflam
viral
exacerb
classic
atop
asthma
two
studi
suggest
recruit
neutrophil
eosinophil
studi
acut
sever
asthma
attack
thought
due
cold
high
number
neutrophil
togeth
high
concentr
found
spontan
expector
sputum
second
studi
six
classic
asthmat
cold
found
modest
sputum
neutrophilia
togeth
high
level
ecp
compar
convalesc
valu
sputum
eosinophil
differenti
count
elev
latter
despit
evid
activ
releas
ecp
inher
difficulti
exist
studi
wildtyp
infect
includ
time
onset
infect
potenti
interviru
differ
problem
collect
invas
sampl
young
children
episod
viral
wheez
establish
model
evw
employ
experiment
infect
use
human
coronaviru
hcov
young
adult
histori
wheez
viral
urt
infect
urti
hcov
second
preval
common
cold
viru
known
associ
exacerb
asthma
children
preschool
wheez
also
symptom
may
virusdepend
import
studi
virus
hrv
previous
report
lrt
symptom
increas
bronchial
respons
evw
subject
occur
symptomat
infect
effect
independ
atopi
report
analysi
model
test
hypothes
symptomat
experiment
urti
hcov
qualit
quantit
differ
lower
respiratori
tract
cellular
infiltr
distinguish
subject
evw
control
cellular
chang
seen
lrt
qualit
similar
natur
seen
urt
associ
quantit
chang
lrt
symptom
chang
bronchial
respons
studi
design
symptom
score
physiolog
measur
report
elsewher
describ
briefli
subject
paid
four
visit
clinic
trial
unit
leicest
children
asthma
centr
well
clinic
physiolog
observ
nasal
lavag
sputum
induct
carri
day
immedi
preced
viru
inocul
repeat
day
later
time
morn
h
princip
aim
studi
mechan
underli
urti
lrt
respons
categor
subject
primarili
symptomat
respons
laboratori
confirm
viral
infect
act
adjunct
valid
model
assist
categor
subject
borderlin
symptom
fortythre
adult
smoke
least
year
recruit
studi
nineteen
healthi
volunt
recruit
local
advertis
histori
evw
recruit
three
local
univers
health
centr
gave
histori
two
episod
wheez
urti
last
year
exerciseinduc
wheez
nocturn
earli
morn
wheez
cough
allergen
dust
pollen
anim
induc
wheez
wheez
respons
cold
air
interv
cold
mean
durat
rang
histori
year
one
subject
previous
label
asthmat
none
use
inhal
corticosteroid
use
b
agonist
relief
urti
none
admit
hospit
respiratori
ill
previou
year
subject
suffer
urti
month
preced
particip
studi
atop
statu
assess
skin
prick
test
reaction
dermatophagoid
pteronyssinu
cat
fur
mix
grass
pollen
compar
histamineposit
salineneg
control
soluprick
alk
frederiksberg
denmark
subject
classifi
atop
basi
one
posit
skin
prick
test
defin
weal
greater
mm
diamet
neg
control
studi
approv
leicestershir
health
author
research
ethic
committe
written
inform
consent
obtain
particip
viral
wheezer
atop
control
seven
atop
inocul
nasal
tissu
cultur
infect
dose
tcid
hcov
previous
describ
subject
monitor
develop
symptom
diari
spirometri
methacholin
bronchial
challeng
perform
prior
sampl
collect
visit
previous
describ
techniqu
nasal
lavag
involv
subject
sit
neck
extend
warm
phosphatebuff
salin
ad
inulin
mgml
introduc
one
nostril
occlud
inulin
use
marker
dilut
measur
inulin
concentr
wash
solut
nasal
lavag
fluid
nlf
obtain
proport
nlf
consist
nasal
secret
calcul
process
subject
occlud
soft
palat
posit
oral
pressur
wash
remain
nasal
caviti
expel
steril
receptacl
kept
ice
weigh
process
within
h
total
ml
aliquot
ml
insert
altern
nostril
ml
total
per
nostril
sputum
induc
use
standard
method
briefli
subject
inhal
mg
salbutamol
metr
dose
inhal
volumat
spacer
min
inhal
nebul
salin
three
period
min
ultrason
nebul
medix
ltd
harlow
uk
output
mlmin
mass
median
diamet
mm
mouthpiec
sputum
expector
subject
blown
nose
gargl
minim
nasal
oral
contamin
sputum
store
ice
weigh
process
within
h
cell
process
perform
assess
qualiti
sampl
cell
viabil
sputum
squamou
contamin
count
leucocyt
perform
differenti
cell
count
process
follow
commonli
use
previous
valid
method
sputum
includ
plug
select
dispers
four
time
volum
dithiothreitol
dtt
sigma
pool
uk
give
final
concentr
gentl
rock
min
dilut
four
volum
dulbecco
phosphatebuff
salin
filtrat
nylon
gauz
nlf
process
similar
way
addit
dilut
minim
use
dtt
concentr
skip
second
dilut
step
sampl
centrifug
g
min
supernat
remov
aliquot
store
total
cell
count
obtain
use
neubauer
haemocytomet
fisher
scientif
loughborough
uk
cell
viabil
assess
trypan
blue
exclus
method
cell
suspens
adjust
cellsml
ml
cell
suspens
use
prepar
cytospin
rpm
min
use
shandon
iii
cytocentrifug
shandon
southern
instrument
sewickley
pa
usa
cytospin
stain
diff
quick
stain
dade
behr
switzerland
code
third
parti
least
cell
count
low
power
order
categor
squamou
cell
bronchial
nasal
ciliat
epitheli
cell
leucocyt
express
percentag
possibl
least
leucocyt
count
high
power
order
determin
sputum
nlf
leucocyt
differenti
nlf
leukocyt
differenti
multipli
total
cell
count
adjust
dilut
effect
nasal
wash
inulindilut
gave
concentr
cell
per
millilitr
nasal
secret
supernat
store
biochem
assay
ifng
measur
enzym
immunoassay
opteia
kit
pharmingen
san
diego
ca
usa
ecp
measur
fluoroenzym
assay
unicap
system
pharmacia
uppsala
sweden
accord
manufactur
instruct
sensit
test
respect
pgml
level
level
detect
elisa
assay
design
half
lower
level
detect
data
analys
dtt
use
mucolyt
sampl
process
significantli
interfer
enzym
immunoassay
demonstr
comparison
assay
recombin
cytokin
without
addit
dtt
sampl
ad
dtt
result
recoveri
protein
compar
sampl
without
dtt
inulin
measur
method
adapt
nasal
secret
cytokin
express
per
millilitr
sputum
nasal
secret
main
outcom
leucocyt
total
differenti
count
solubl
mediat
concentr
sputum
eosinophil
lymphocyt
count
nlf
cell
count
normal
distribut
log
transform
normal
sputum
eosinophil
lymphocyt
prior
analysi
baselin
baselin
comparison
sputum
differenti
count
group
analys
student
unpair
ttest
baselin
comparison
group
nlf
cell
count
solubl
mediat
analys
mannwhitney
utest
chang
baselin
sputum
differenti
count
sputum
nlf
concentr
day
normal
distribut
analys
use
repeat
measur
manova
analysi
techniqu
allow
investig
chang
time
within
group
time
effect
differ
group
group
effect
differ
effect
time
group
timegroup
interact
solubl
mediat
ifng
ecp
neutrophil
cell
count
nlf
markedli
skew
therefor
analys
use
mannwhitney
utest
relationship
chang
neutrophil
assess
pearson
correl
lrt
spearman
rank
correl
urt
chang
neutrophil
day
also
compar
chang
log
pc
methacholin
symptom
score
day
taken
data
report
previous
pearson
correl
spearman
rank
correl
accord
data
distribut
subject
characterist
clinic
physiolog
respons
infect
report
previous
femal
evw
group
control
group
respect
atop
respect
age
similar
mean
age
sd
year
respect
despit
evw
group
lower
baselin
fev
pef
differ
airway
respons
baselin
eight
subject
allerg
rhiniti
four
group
one
evw
subject
fail
attend
day
data
includ
nineteen
evw
subject
control
develop
symptomat
cold
sixteen
evw
subject
control
symptomat
cold
laboratori
evid
hcov
infect
laboratori
evid
viru
infect
includ
analysi
inflamm
none
evid
coincident
wildtyp
infect
rhinoviru
adenoviru
influenza
viru
b
rsv
parainfluenza
virus
determin
cultur
nose
throat
swab
taken
first
week
studi
howev
symptom
diari
suggest
nine
wild
cold
occur
latter
half
studi
henc
day
data
subject
exclud
sixteen
evw
subject
symptomat
cold
develop
lrt
symptom
wheez
short
breath
chest
tight
control
develop
lrt
symptom
evw
subject
minor
reduct
fev
pef
day
lrt
symptom
progress
reduct
log
pc
gl
baselin
gl
day
inocul
affect
atop
nonatop
subject
equal
see
refer
detail
physiolog
result
chang
control
without
cold
sputum
cell
count
avail
occas
possibl
follow
reason
failur
expector
sampl
nonattend
less
leucocyt
count
cytospin
sampl
exclud
day
due
intercurr
wild
infect
nasal
lavag
data
obtain
occas
possibl
follow
reason
nasal
sport
injuri
nonattend
sampl
exclud
day
due
wild
infect
vast
major
nasal
lavag
sampl
obtain
throughout
studi
produc
return
volum
greater
ml
day
symptomat
phase
ill
volum
nlf
return
mean
ci
ml
inulinadjust
volum
mean
ci
ml
viabil
cell
gener
good
cold
nasal
sampl
rang
sputum
sampl
rang
final
squamou
contamin
gener
median
sputum
sampl
greater
nasal
sampl
median
nasal
sampl
median
valu
cell
type
nlf
zero
subject
group
baselin
signific
differ
group
small
increas
total
leucocyt
cell
count
seen
group
cold
tabl
largest
chang
baselin
seen
day
larger
evw
group
small
increas
nasal
lavag
neutrophil
count
group
cold
studi
signific
differ
two
group
tabl
neutrophil
predomin
nlf
cell
throughout
studi
signific
correl
chang
nlf
neutrophil
urt
symptom
score
day
r
p
seen
day
r
p
differ
atop
n
nonatop
n
subject
evw
group
cold
chang
neutrophil
count
baselin
day
median
chang
quartil
ml
respect
p
signific
chang
eosinophil
either
atop
nonatop
subject
cold
evw
group
median
chang
quartil
baselin
day
ml
respect
sputum
sampl
small
increas
total
leucocyt
cell
count
seen
group
cold
tabl
chang
seen
subject
without
symptomat
cold
differ
seen
group
baselin
cell
differenti
count
tabl
signific
increas
proport
sputum
neutrophil
seen
evw
group
cold
day
return
toward
baselin
day
p
reciproc
effect
proport
macrophag
p
tabl
fig
effect
control
group
cold
differ
group
signific
p
differ
seen
sputum
lymphocyt
eosinophil
studi
inde
low
number
cell
present
relationship
chang
neutrophil
chang
symptom
score
day
day
maxim
chang
neutrophil
explor
signific
correl
r
p
found
howev
signific
correl
chang
sputum
neutrophil
total
lrt
symptom
score
whole
studi
period
r
p
baselin
signific
differ
evw
control
group
measur
urt
lrt
signific
differ
baselin
ecp
atop
n
nonatop
n
subject
evw
either
urt
median
quartil
pgml
nasal
secret
respect
p
lrt
median
quartil
pgml
sputum
supernat
respect
p
signific
chang
studi
tabl
mediat
nlf
sputum
control
without
cold
n
data
therefor
present
symptomat
cold
nasal
sampl
subject
evw
cold
trend
toward
increas
nasal
day
return
toward
baselin
day
seen
control
fig
signific
differ
atop
nonatop
subject
cold
chang
day
mean
differ
ci
pgml
respect
p
although
atop
subject
tend
higher
valu
subject
cold
nlf
ifng
concentr
level
detect
although
level
increas
subject
cold
increas
modest
signific
differ
group
overal
chang
nasal
ecp
although
subject
group
modest
increas
day
subgroup
analysi
atop
nonatop
evw
subject
cold
day
also
show
signific
differ
median
quartil
pgml
p
respect
assay
sensit
pgml
major
subject
group
timepoint
signific
correl
chang
concentr
urt
symptom
score
day
r
p
p
respect
howev
chang
concentr
day
significantli
correl
total
urt
score
whole
studi
period
r
p
weak
signific
correl
found
chang
neutrophil
baselin
day
r
p
thu
signific
interrelationship
urt
symptom
neutrophil
count
ill
sputum
sampl
cold
signific
increas
sputum
seen
evw
group
day
return
toward
baselin
day
tabl
fig
pattern
seen
control
signific
differ
group
tabl
subject
cold
ifng
level
detect
although
cold
increas
modest
signific
differ
group
signific
chang
sputum
ecp
either
group
subgroup
analysi
atop
evw
subject
cold
also
show
signific
chang
baselin
median
quartil
ecp
day
pgml
respect
p
major
sampl
level
level
detect
assay
chang
sputum
concentr
baselin
day
postinocul
weakli
correl
lrt
neutrophil
differenti
count
r
p
lrt
symptom
score
day
r
p
total
lrt
symptom
score
r
p
increasingli
recogn
within
asthma
syndrom
especi
young
children
phenotyp
independ
atopi
airway
hyperrespons
von
mutiu
recent
put
forward
idea
compon
asthma
syndrom
relat
atopi
specul
keep
observ
question
core
recent
understand
pathophysiolog
asthma
establish
adult
model
viral
wheez
individu
without
typic
allerg
asthma
phenotyp
order
studi
inflammatori
characterist
particular
phenotyp
conjunct
report
physiolog
chang
model
evw
studi
provid
firm
evid
phenotyp
evw
distinct
classic
atop
asthma
strongli
implic
neutrophil
process
qualit
quantit
differ
demonstr
asymptomat
subject
evw
control
baselin
howev
qualit
quantit
differ
subject
evw
control
found
inflamm
upper
lower
respiratori
tract
symptomat
cold
subject
evw
signific
rel
neutrophilia
sputum
seen
control
associ
higher
concentr
sputum
symptomat
cold
neutrophilia
associ
lrt
symptom
previous
report
group
evid
increas
leucocyt
upper
lower
respiratori
tract
cold
although
small
number
control
make
quantit
comparison
insensit
similar
inflammatori
respons
urt
lrt
observ
neutrophil
seem
key
cell
site
evw
group
wherea
eosinophil
product
first
time
upper
lower
respiratori
tract
inflamm
studi
experiment
infect
hcov
first
time
associ
elev
nasal
level
hcov
common
cold
shown
confirm
similar
find
hrv
wild
infect
also
establish
associ
symptom
neutrophil
inflamm
upper
lower
respiratori
tract
evid
support
involv
th
associ
process
eosinophil
recruit
eosinophil
activ
stevenson
et
al
studi
opportunist
collect
bal
fluid
young
children
histori
evw
found
evid
chronic
inflamm
asymptomat
period
contrast
atop
asthmat
increas
eosinophil
mast
cell
differenti
count
confirm
asymptomat
interv
evw
character
chronic
inflamm
lrt
also
demonstr
eosinophil
involv
acut
ill
appear
case
either
natur
viral
exacerb
experiment
infect
atop
asthmat
although
experiment
infect
advantag
homogen
subject
select
time
inocul
use
singl
viru
strain
interpret
take
account
design
technic
aspect
methodolog
design
experiment
infect
laboratori
strain
viru
differ
sever
respect
wild
infect
abil
cultur
viru
trigger
lrt
symptom
may
well
affect
attenu
well
unknown
virusspecif
factor
although
prove
case
previou
studi
dose
rout
inocul
clearli
differ
wild
situat
minor
import
present
studi
effect
proof
principl
evw
distinct
disord
volunt
inocul
activ
viru
possibl
may
asymptomat
infect
respond
mediat
suspens
medium
inflammatori
respons
asymptomat
infect
would
act
minim
differ
symptomat
asymptomat
group
affect
differ
viral
wheezer
control
clinic
cold
shaminfect
group
would
requir
exclud
interfer
recent
publish
data
group
suggest
activ
viru
produc
asymptomat
pathogen
effect
urt
epithelium
medium
contain
ultraviolet
treat
henc
inactiv
viru
pathogen
effect
two
group
ident
mani
characterist
although
atop
viral
wheez
group
atopi
thought
predispos
individu
sever
urt
ill
experiment
hrv
infect
studi
could
confound
factor
howev
find
atopi
factor
develop
urt
symptom
hyperrespons
nasal
neutrophil
respons
model
although
number
small
nine
seven
atop
nonatop
respect
viral
wheez
group
cold
allerg
rhiniti
also
known
predispos
subject
sever
urt
symptom
four
subject
histori
allerg
rhiniti
group
unlik
account
inflammatori
respons
seen
technic
repeat
sputum
induct
h
apart
use
high
dose
hyperton
salin
ml
mlmin
caus
concentr
ecp
neutrophil
count
increas
approxim
pavord
review
problem
suggest
effect
may
relat
dose
hyperton
salin
use
present
studi
use
less
half
amount
hyperton
salin
given
rate
mlmin
chang
neutrophil
seen
sputum
control
without
cold
despit
repeat
induct
h
apart
repeat
nasal
lavag
could
wash
convers
recruit
cell
nasal
epithelium
repeat
studi
subject
without
cold
good
agreement
cell
count
repeat
nlf
interv
intraclass
correl
coeffici
respect
slightli
poorer
repeat
day
suggest
effect
cell
recruit
washout
recruit
problem
current
studi
asymptomat
control
cell
nlf
stage
minor
washout
effect
would
diminish
real
differ
group
recent
studi
demonstr
addit
proteas
inhibitor
markedli
enhanc
recoveri
cytokin
particular
sputum
could
one
reason
found
undetect
level
mani
factor
believ
import
pathogenesi
evw
exacerb
wheez
associ
one
wide
rang
infect
viral
strain
suggest
host
respons
factor
rather
viru
specif
predomin
either
heighten
abnorm
inflammatori
respons
viru
infect
undu
physiolog
respons
normal
inflamm
form
bronchial
hyperrespons
could
central
abnorm
wheez
respons
clear
evid
rel
neutrophilia
lrt
along
elev
evw
group
also
demonstr
two
studi
wild
type
viru
exacerb
atop
asthma
latter
also
found
eosinophilia
increas
ecp
lrt
low
level
eosinophil
ecp
present
studi
suggest
eosinophil
import
evw
differ
cellular
physiolog
respons
atop
nonatop
subject
evw
mechan
atopi
eosinophil
inflamm
must
involv
evw
adult
evw
suffer
urt
symptom
similar
healthi
control
although
studi
trend
toward
sever
symptom
greater
degre
neutrophil
nasal
inflamm
lrt
neutrophilia
appear
specif
evw
subject
tradit
propos
neutrophil
limit
damag
caus
viral
respiratori
tract
infect
although
may
also
caus
tissu
damag
releas
cytotox
granulederiv
protein
elastas
myeloperoxidas
free
radic
lipidderiv
mediat
ltb
neutrophil
caus
lrt
tissu
damag
wheez
clearli
cell
could
involv
pathogenesi
evw
studi
viral
urti
except
respiratori
syncyti
viru
rsv
bronchiol
found
direct
relationship
lrt
neutrophil
cell
differenti
count
lrt
symptom
seem
like
factor
also
involv
evw
suggest
cascad
differ
mechan
recruit
activ
lymphocyt
releas
proinflammatori
cytokin
chemokin
airway
remodel
alter
neural
respons
combin
produc
chang
airway
physiolog
demonstr
increas
evid
common
respiratori
virus
directli
infect
lret
might
directli
influenc
mechan
inflamm
import
ill
search
potenti
therapeut
intervent
focu
stimulu
mechan
lrt
cell
recruit
role
symptom
product
possibl
indirect
mechan
could
link
urt
lrt
remain
sever
potenti
link
exist
nasal
provoc
cold
air
shown
produc
increas
airway
resist
seen
stimulu
deliv
mouth
asthmat
suggest
presenc
nasobronchi
neural
reflex
nose
also
play
import
protect
role
lrt
condit
filter
inspir
air
also
abil
gener
immun
respons
possibl
nasal
immun
respons
cell
activ
lrt
effect
via
circul
cell
mediat
need
explor
mechan
requir
host
factor
discrimin
healthi
wheezi
subject
independ
atopi
report
role
inflamm
urt
lrt
experiment
hcov
infect
adult
histori
evw
demonstr
modest
neutrophil
inflamm
lrt
evw
subject
evid
eosinophil
accumul
activ
neutrophil
like
involv
mechan
lead
evw
basi
excess
accumul
evw
sought
